Metabolically Healthy Obesity
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Obesity contributes to reduced life expectancy, impaired quality of life, and disabilities, mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis, and cancer. However, there is a large variation in the individual risk to developing obesity-associated comorbid diseases that cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the concept of metabolically healthy obesity (MHO). Although there is no clear definition, normal glucose and lipid metabolism parameters—in addition to the absence of hypertension—usually serve as criteria to diagnose MHO. Biological mechanisms underlying MHO lower amounts of ectopic fat (visceral and liver), and higher leg fat deposition, expandability of subcutaneous adipose tissue, preserved insulin sensitivity, and beta-cell function as well as better cardiorespiratory fitness compared to unhealthy obesity. Whereas the absence of metabolic abnormalities may reduce the risk of type 2 diabetes and cardiovascular diseases in metabolically healthy individuals compared to unhealthy individuals with obesity, it is still higher in comparison with healthy lean individuals. In addition, MHO seems to be a transient phenotype further justifying therapeutic weight loss attempts—even in this subgroup—which might not benefit from reducing body weight to the same extent as patients with unhealthy obesity. Metabolically healthy obesity represents a model to study mechanisms linking obesity to cardiometabolic complications. Metabolically healthy obesity should not be considered a safe condition, which does not require obesity treatment, but may guide decision-making for a personalized and risk-stratified obesity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hyperplasia, referring to an increase in the number of adipocytes, is associated with an increase in subcutaneous fat volume and protective signals, and is associated with MHO (50).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“On the contrary, hypertrophic adipocytes, in which existing adipocytes enlarge, is associated with increased dysfunction and MUHO (50), which contributes to IR and subsequent T2D (52, 53).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 7×
“8 Endocrine Reviews, June 2020, 41(3):1–16 Blüher Metabolically Healthy Obesity sex hormones may play a role in the transition from MHO to MUO.”
BackgroundInfluentialSelf-citationThe global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Cited by
Items 901–999 of 999
Samuelsson, M. G., López, P. J. T., López‐González, Á. A., Busquets-Cortés, C., de Hevia, J. O., & Ramírez‐Manent, J. I. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500840
He, J., Shan, L., Yu, L., Yu, L., Jiang, X., Shen, Y., Du, Z., Yu, R., Zhao, C., Du, X., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5381069
Jeelani, I., da Cunha, F. F., Rohm, T. V., Nasamran, C. A., Moon, J.-S., Wang, L., Prakash, S., Issac, R., Murphy, C., Glass, C. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.670151
Rola, P., Dróżdż, O., Doroszko, A., Trocha, M., Kujawa, K., Bronowicka-Szydełko, A., Matera-Witkiewicz, A., Bednarska-Chabowska, D., Rabczyński, M., Kuźnik, E., et al. (2025) · Advances in Medical Sciences · doi:10.1016/j.advms.2025.08.002
Ugwu, O. P.-C., Ugwu, M. N., Basajja, M., & Anyanwu, C. N. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100639 · Cited by 1
Rani, C. A. L. J. A., Gowda, R. N., Muniswamy, V., Srinivas, A., Prashant, A., Vishwanath, P. M., & Ramachandra, S. C. (2025) · BMJ connections. · doi:10.1136/bmjccgg-2025-000034 · Cited by 1
Svensson, S. I. A., Hoffmann, A., Hagemann, T., Çayır, A., Saeed, S., Ghosh, A., Wolfrum, C., Blüher, M., & Böttcher, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1647477
“All patients were extensively clinically phenotyped regarding obesity, metabolic variables and anthropometric traits as described by Blüher (2020) and Klöting et al. (2010) (21, 22).”
Self-citationGimsa, U., Koczan, D., Kanitz, E., Tuchscherer, A., & Rebl, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1601809
Zhang, Y., Jiang, Z., Li, J., Wang, F., Liu, Y., Song, M., & Li, X. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107576
Potential markers of obesity linked to the gut microbiome
Ganenko, L. A., Волкова, Н. И., Shestopalov, A. V., Naboka, Y. L., & Зибарев, А. Л. (2025) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2025-16-3-67-74
Nasien, D., Owen, S., Fenly, F., Johanes, J., Lombu, F., Leo, L., & Baharum, Z. (2025) · Journal of Applied Business and Technology · doi:10.35145/jabt.v6i3.201
Chen, J., Miao, Y., Li, Q., Zhang, Q., Sun, B., Wu, Z., Liu, W., Liu, J., Shi, H., Gao, H., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1648996 · Cited by 2
Disturbed Glycometabolism‐Induced Chondrocyte Apoptosis Contributes to TMJOA
Zhang, Y., Cai, L., Cui, S., Guo, Y., Hu, N., Zhang, Y., Gan, Y., Zhang, J., & Wang, X. (2025) · Oral Diseases · doi:10.1111/odi.70011
“…syndromes (Zhuo et al. 2012), including hyperglycemia (Piñeiro-Ramil et al. 2022; Li et al. 2021), hypertension (Ching et al. 2021), high cholesterol levels (de Munter et al. 2016), and altered obesity-related metabolic factors (Blüher 2020), highlights the crucial role of abnormal glycometabolism.”
Makram, O. M., Shah, V., Nahle, T., Wang, X., Harris, R. A., Coughlin, S. S., Weintraub, N. L., Joshu, C. E., Platz, E. A., & Guha, A. (2025) · medRxiv · doi:10.1101/2025.11.17.25340450 · Cited by 1
Brown adipocytes from pluripotent stem cells: a promising therapy for obesity
Ha, M., Leng, T., Jiang, J., Ma, X., Chen, Y., Hu, T., Huang, Y., & Rao, C. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11281-w · Cited by 1
Saeed, S., Hoffmann, A., Svensson, S. I. A., Visnovska, T., Hagemann, T., Ghosh, A., Wolfrum, C., Çayır, A., Mala, T., Kristinsson, J. A., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01391-3
“All patients were extensively clinically phenotyped as previously described (Bluher 2020; Kloting et al. 2010).”
Self-citationDiet and Brain Development and the Importance for Modern Man
Biesalski, H. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-99121-9_12
Targeting Adipose Tissue Function Protects Against Heart Failure with Preserved Ejection Fraction
Jousma, J., Han, Z., Park, J., Yan, G., Zhang, S., Kwon, Y., Nukala, S. B., Kandola, J., Pinho, S., Liew, C. W., et al. (2025) · Advanced Science · doi:10.1002/advs.202506106 · Cited by 1
Predictors of cardiovascular outcomes in individuals with different obesity phenotypes
Berezenko, I. L., Филиппов, Е. В., & Volchenkova, M. V. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252811159
Samuelsson, M. G., López, P. J. T., López‐González, Á. A., Busquets-Cortés, C., de Hevia, J. O., & Ramírez‐Manent, J. I. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500840
Lei, J., Zhuang, Y., Tang, S., Chen, Y., Han, Y., Zhao, Y., Liu, Y., & Fan, Z. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104514
Müller‐Wieland, D., & Marx, N. (2024) · Springer eBooks · doi:10.1007/978-3-662-69938-6_12
Hany, M., Eldeeb, M. K., Elmongui, E., Abouelnasr, A. A., El-Banna, N. A., Omer, S. M., Shaker, S. A., & ElTahan, R. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-29899-y · Cited by 1
“Collectively, the evidence from Woodward et al. 68 , Blüher 60 , Aguilar-Salinas et al. 69 , Kalkman 67 , Fuster et al. 68 , Han et al. 71 , and Ahl et al. 70 supports the interpretation that elevated adiponectin in obesity represents a physiological adaptation rather than a contradiction of prior literature.”
InfluentialWang, Z., He, Y., Li, L., Zhang, M., Ruan, H., Zhu, Y., Wei, X., Wei, J., Chen, X., & He, S. (2022) · Figshare · doi:10.6084/m9.figshare.20727590
Sbierski‐Kind, J., Goldeck, D., Buchmann, N., Spranger, J., Volk, H.-D., Steinhagen-Thiessen, E., Pawelec, G., Demuth, I., & Spira, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467435
Strack, C., Behrens, G., Sag, S. J. M., Mohr, M., Zeller, J., Lahmann, C., Hubauer, U., Loew, T., Maier, L. S., Fischer, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311671
Korduner, J., Holm, H., Jujić, A., Melander, O., Pareek, M., Molvin, J., Råstam, L., Lindblad, U., Daka, B., Leósdóttir, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20222015
Korduner, J., Holm, H., Jujić, A., Melander, O., Pareek, M., Molvin, J., Råstam, L., Lindblad, U., Daka, B., Leósdóttir, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20222012
Elías-López, D., Vargas‐Vázquez, A., Mehta, R., Cruz Bautista, I., Razo-Olvera, F. M. D., Gómez‐Velasco, D., Almeda Valdes, P., & Aguilar-Salinas, C. A. (2021) · Figshare · doi:10.6084/m9.figshare.14509807
Dong, H., Guo, H., Du, J., Cheng, Y., Wang, D., Han, J., Yuan, Z., Yao, Z., An, R., Wu, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24761528
Elías-López, D., Vargas‐Vázquez, A., Mehta, R., Cruz Bautista, I., Razo-Olvera, F. M. D., Gómez‐Velasco, D., Almeda Valdes, P., & Aguilar-Salinas, C. A. (2021) · Figshare · doi:10.6084/m9.figshare.14509810
Liu, X., Abudukeremu, A., Jiang, Y., Cao, Z., Wu, M., Ma, J., Sun, R., He, W., Chen, Z., Chen, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590398
Ler, P., Li, X., Hassing, L. B., Reynolds, C. A., Finkel, D., Karlsson, I. K., & Aslan, A. K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19582362
Mir, F. A., Mall, R., Ullah, E., Iskandarani, A., Cyprian, F., Samra, T. A., Alkasem, M., Abdalhakam, I., Farooq, F., Taheri, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22626289
Retnakaran, R., & Shah, B. R. (2022) · Figshare · doi:10.6084/m9.figshare.21500776
Wang, Z., He, Y., Li, L., Zhang, M., Ruan, H., Zhu, Y., Wei, X., Wei, J., Chen, X., & He, S. (2022) · Figshare · doi:10.6084/m9.figshare.20727593
Wang, Z., He, Y., Li, L., Zhang, M., Ruan, H., Zhu, Y., Wei, X., Wei, J., Chen, X., & He, S. (2022) · Figshare · doi:10.6084/m9.figshare.20727599
Additional file 1 of Long-term impact of the metabolic status on weight loss-induced health benefits
Soll, D., Gawron, J., Pletsch‐Borba, L., Spranger, J., & Mai, K. (2022) · Figshare · doi:10.6084/m9.figshare.19445318
Korduner, J., Holm, H., Jujić, A., Melander, O., Pareek, M., Molvin, J., Råstam, L., Lindblad, U., Daka, B., Leósdóttir, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20222018
Korduner, J., Holm, H., Jujić, A., Melander, O., Pareek, M., Molvin, J., Råstam, L., Lindblad, U., Daka, B., Leósdóttir, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20222021
Wang, Z., He, Y., Li, L., Zhang, M., Ruan, H., Zhu, Y., Wei, X., Wei, J., Chen, X., & He, S. (2022) · Figshare · doi:10.6084/m9.figshare.20727596
Neue Kriterien zur Definition und Diagnostik der Adipositas?
Blüher, M. (2025) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2606-0632
“Für Menschen gleichen Al-ters und gleichen Geschlechts gibt es bei gleichem BMI eine große Phänotypvarianz in der Ausprägung von Adipositas-Begleiterkran-kungen [9–11].”
InfluentialSelf-citationPan, P., Yang, Y., Kuang, H., Du, H., He, S., & Chen, X. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04233-6
Abdominal versus femoral subcutaneous fat gene expression in non-obese insulin resistant individuals
Badran, S. M., Almuraikhy, S., Alser, M., Naja, K., Anwardeen, N. R., Abunada, H. H., Ahmed, M. B., Jarrar, S. I., Aljassem, G., Iskeirjeh, S., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1684761
“However, recent studies have indicated that not all obese individuals are insulin resistant (3).”
Khanna, S., Wang, N., Bhat, A., Arnott, C. G., & Nerlekar, N. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70479 · Cited by 1
Saha, A. K., Mahato, P., Ray, A. K., Chatterjee, I., & Mukherjee, M. (2026) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20260136
Korduner, J., Isholth, H. H., Jujić, A., Engström, G., Kylhammar, D., Engvall, J. E., Magnusson, M., Gottsäter, A., & Nilsson, P. M. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05551-z
“We found that these individuals presented with a more favorable glucose-and lipid profile compared to individuals with obesity and impaired LVFR or AH, suggesting a more stable metabolic control compatible with the MHO phenotype, described in previous studies [30].”
Impact of obesity on aromatic amino acids and brain glucose during acute hyperglycemia
Matson, B. C., Gunawan, F., Rothman, D. L., Mason, G. F., Ilkayeva, O., Newgard, C. B., & Hwang, J. J. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00463.2025
Poutanen, J., Härmä, M., Lallukka, T. M., Joensuu, M., Haukka, E., Koskinen, A., Ervasti, J. M., & Shiri, R. (2026) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-025-02200-4 · Cited by 2
“Although obesity is a risk factor for several diseases and contributes to a reduced life expectancy, significant pro - portion of those living with obesity could be metabolically healthy, which is more prevalent among women (Bluher 2020).”
Xie, B., Li, J., Huang, G., Zhao, Y., Chen, D., Wei, L., Guo, F., Florentino, R. M., Faccioli, L. A. P., Kurihara, T., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101002
“This condition significantly increases the risk of severe comorbidities, including type II diabetes, atherosclerosis, hepatic steatosis, and other malignancies (2 – 4).”
Identification of a novel long non-coding RNA (LOC105377284) regulating PPARγ-dependent adipogenesis
Basar, M., Önal, M. G., Akkuş, A., Kara, C. Ş., & Bayram, F. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11576-6
Huang, J., Hong, B., Chen, X., Jiang, F., & Chen, Y. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2633804 · Cited by 2
“It is clinically defined as by the co-occurrence of excess adiposity and cardiometabolic dysregulation, including IR, atherogenic dyslipidemia, and hypertension [16].”
InfluentialAkhmedova, Z. G. A., & Kagramanova, D. I. (2026) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.22.1.2026.1672
Obesity and melanoma: unraveling the paradoxical survival benefit in immunotherapy
Yang, J., Hu, Q., & Xue, C. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10324-3
Zaragoza-García, Ó., Gutiérrez-Pérez, I. A., Villafán-Bernal, J. R., Delgado‐Floody, P., Alarcón-Paredes, A., Sánchez-Alemán, M. Á., Rodríguez-García, R., Navarrete, F. C., & Guzmán‐Guzmán, I. P. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01905-8
“Obesity is associated with an increased risk of all-cause and cardiovascular mortality [1 ], and distinct metabolic phenotypes have been identified in people with obesity [2 ].”
Age-reversed weight-mortality links in diabetes or prediabetes: evidence from NHANES
Zhang, Z., Gu, P., Yang, W., Wen, Y., Lei, P., Hao, T., Man, C., Niu, W., & Zhu, G. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01896-6
“…reveal that increased weight variability in person with diabetes correlates positively with Zheng Zhang, Peng Gu and Wucai Yang contributed equally to this work. all-cause and cardiovascular-specific mortality, potentially mediated by metabolic instability or latent pathological processes [5].”
Ying, S., Ding, H., Chen, Y., & Zheng, S.-F. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004184
LUMULA, F., Kurniawan, L. B., Nurahmi, N., SANUSI, H. D., Esa, T., & ZAINUDDIN, A. A. (2026) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.25.05986-8
Yuri, G., Santillana, N., Soto, L., Pereira, A., Corvalán, C., & Cifuentes, M. (2026) · Journal of Obesity · doi:10.1155/jobe/5233463
OZKAN, E., KOCATEPE, N., & Avuk, H. S. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04412-3 · Cited by 1
“Since VAI is specifically sensitive to visceral adipose dysfunction and TG levels, it may not fully capture the subcutaneous adiposity load that drives PMS-related inflammation in this younger, non-diabetic cohort [36].”
Skurk, T., Raab, H., & Riedl, M. (2026) · Springer eBooks · doi:10.1007/978-3-662-69828-0_9
Mas, M. (2020) · theses.fr (ABES) · doi:10.70675/2acbede7ze0d9z4b79z92d2zac21e057d5b5 · Cited by 1
Ketogenic Diet Effect on Weight Loss and Lipids in Obesity
Pratiwi, I. G. A. I., & Harimawan, A. I. W. (2026) · International Journal of Research and Review · doi:10.52403/ijrr.20260333
Miller, A., Coleman, C. D., Kiel, J., Beavers, K. M., & Jonnalagadda, S. S. (2026) · Obesity Pillars · doi:10.1016/j.obpill.2026.100265
“In addition to weight reduction, improving key cardiometabolic risk factors, including central adiposity, glycemic control, blood pressure, and blood lipids, is central to improving metabolic health and lowering the risk of downstream chronic disease [1,4,6,8 – 10].”
MEYVACI, S. S., Seçgin, Y., Ülger, T. G., T, T. D., B, C., & Demiroglu, S. (2026) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/18013
Pessoa, E. C., Bagnoli, F., Madeira, M., Araujo, J. T., Tosello, G. T., Brenelli, F. P., Geronymo, B. B., Buttros, D. D. A. B., Cabello, C., Baccarin, A. L. D. C., et al. (2026) · Mastology · doi:10.29289/2594539420250028
Bilici, M. E. (2026) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-026-02262-1
“The literature generally indicates that the MHO group tends to be younger, more common in girls, and characterized by lower BMI SDS values [5, 7, 8, 40, 41].”
The association between primary bile acids and metabolically unhealthy obesity
Zong, M., Wu, C., Zhao, S., Kong, L., Li, W., Shi, J., Chen, Y., Ye, Y., Gao, A., Ning, G., et al. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101761
Xu, Z., Wang, Y., Xiang, J., Zhou, C., Zhang, X., Wang, J., Yue, S., Hou, X., Wu, J., & Zeng, Z. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103300
Ren, H., Xiao, Y., Tang, Z., Shi, Y., Zeng, Z., Tang, B., He, X., & Xiao, R. (2026) · Dermatologic Therapy · doi:10.1155/dth/8727416
Aleksanin, S. S., Тихомирова, О. В., Zybina, N. N., Lomova, I. P., Кожевникова, В. В., & Александровна, Г. М. (2026) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2025-53-028
López-Cancel, A. A., Navas-Rosado, J., Vélez-Maldonado, D. A., Aguirre-Hernández, J. M., Rodríguez-Torruella, D., Motta-Pagán, J. L., Derieux-Cruz, J., Rosario-Maldonado, F. J., Torres-Ruiz, W., Rodríguez-Rodríguez, D., et al. (2026) · Obesities · doi:10.3390/obesities6030026
Couple-level metabolic phenotypes and self-rated health in Korean adults
Lee, K. (2026) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2026.04.009
Ran, X., Fan, Z., Wang, N., Zhao, T., Li, H., Liu, X., Gong, E., Xie, S., Gao, B., An, L., et al. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s593341
Agbonifo, W. O., Chimezie, J., Awoleye, M. O., Francis, H. O., Oguntade, I. A., Aleruwa, S. O., Amoo, Z. A., & Adedeji, T. G. (2026) · The Journal of Nutritional Physiology · doi:10.1016/j.jnphys.2026.100031
Mohammed, A. S., Desai, R., Manne, S., Gogikar, A., Tera, C. R., Oble, M. J. P., Nair, A., Nawab, S., Polamarasetty, H., Srivastava, A. A., et al. (2026) · World Journal of Clinical Cases · doi:10.12998/wjcc.v14.i15.118960
Yáñez-Sepúlveda, R., Olivares, R., Guzmán-Muñoz, E., Concha‐Cisternas, Y., de Souza-Lima, J., García-Carrillo, E., Páez‐Herrera, J., Rojas‐Valverde, D., Cortés-Roco, G., Clemente‐Suárez, V. J., et al. (2026) · Clinical Obesity · doi:10.1111/cob.70081
“…in adolescents, where the relationship between BMI and cardiometabolic risk is complex [1] and may not be linear [29], and where greater muscle development can provide a protective effect [30], even in individuals with high body weight, a phenomenon known as ‘metabolically healthy obesity’ [31].”
Wu, X., Wu, M., Du, S., Liu, J., Wang, R., Sun, Y., Zheng, Z., Yang, J., Jia, X., Wang, L., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101061
“The healthy adipose lead to substantial whole-body metabolic benefits (34, 35).”
Gutin, I. (2026) · Social Science & Medicine · doi:10.1016/j.socscimed.2026.119424
Anvarova, S., Narimova, G., Alieva, A., Khalimova, Z., Kholova, D. S., & Sadikova, A. (2026) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2026.100309
A conserved transcriptomic model defines metabolic resilience and vulnerability in obesityPreprint
Su, Y.-Y., Bundalian, L. T., Chen, Y.-C., Gjermeni, E., Gille, B., Richter, S., Jasaszwili, M., Palma-Vera, S., Hoffmann, A., Ghosh, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726524
Self-citationGhannadiasl, F. (2026) · Women & Health · doi:10.1080/03630242.2026.2675280
“…in abdominal area, is a significant risk factor for various health issues, including cardiometabolic diseases (Wang et al. 2024), diabetes (Blüher 2020), dyslipidemia (Blüher 2020), metabolic dysfunction-associated fatty liver disease (Cen et al. 2024), and chronic kidney disease (Cen et…”
Chang, M.-L., Cai, J.-H., Hsu, T.-C., Tseng, Y.-T., & Liu, I. (2026) · Journal of Food Biochemistry · doi:10.1155/jfbc/3734609
Comparing multiple definitions of obesity in a large nationwide health program
Szöllösi, G. J., Csenteri, O. K., Andreka, P. G., Andréka, L., Jancsó, Z., & Vajer, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-53073-7
Han, Y., Choi, Y., Lee, S., & Kim, Y. S. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70882
“…liver and visceral fat, relatively preserved lower-body subcutaneous fat distribution, greater cardiorespiratory fitness and physical activity, better insulin sensitivity, lower inflammatory burden, and more preserved adipose tissue function than their metabolically unhealthy counterparts [28].”
Urinary bisphenol A analogues and metabolically unhealthy obesity in school-age children
Hu, G., Zhang, Z., Wei, X., Huang, Y. L., Zhan, M., Bai, P., He, G., & zhou, Y. H. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128446
Bordoni, L., Mansouri, F., Rucci, C., de Sousa, J. A., & von Meyenn, F. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106703 · Cited by 2
Meng, Q., Zhang, Z., Lv, L., Wang, X., Wang, L., Ji, L., Li, X., Ma, C., & Zhang, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1828999
“This phenomenon is similar in mechanism to the concept of “meta-bolically healthy obesity,” which suggests that the preserved insulin sensitivity may lessen the cardiometabolic risks associated with obesity (40, 41).”
“Yeah but …”: shifting our mindset around body weight in organizational research
Lemmon, G., Jensen, J. M., & Kuljanin, G. (2026) · Equality Diversity and Inclusion An International Journal · doi:10.1108/edi-08-2025-0575
Tan, M., Tang, X., Nan, W., Peng, Z., & Xing, Z. (2026) · Obesity Facts · doi:10.1159/000552804
Abdulwasiu, A. O., & Benson, K. D. (2026) · Journal of the Nigeria Association of Sports Science and Medicine · doi:10.66986/jnassm.2026.1901.12-j
Estrogen prevents menopausal obesity
Maturana, M. A., Satler, F., & Naftolin, F. N. (2026) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002806
Simioni, L., Bennar, W., Beretta, G. S., Pittet, T., Cioffi, G. M., Jelisejevas, J. J., Wenaweser, P., Meier, P., Puricel, S., Togni, M., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060251
Body Mass Index Versus Body Composition for Risk Stratification in Craniofacial Surgery
Munkwitz, S. E., Sandino, A. I., Patel, J., Coelho, P. G., & Thaller, S. R. (2026) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000013024
Unsupervised Deep Autoencoder-Based Clustering for mining the Metabolic Syndrome
Palouj, H., & Hajihasani, M. (2025) · International Conference on Signal Processing and Intelligent Systems (ICSPIS) · doi:10.1109/icspis68676.2025.11551743
Yılmaz, E., Yılmaz, Z. Y., Dündar, İ., Çamtosun, E., & Topal, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124480
Xu, Y., Yang, H., Xu, Q., Yu, X., Dai, S., Zhang, X., Shen, W., & Zhu, X. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00727-2
“Another epidemiological study also confirmed that MHO patients have a higher long-term ASCVD and type 2 diabetes prevalence and a higher all-cause mortality rate [ 74].”
Association between different metabolic phenotypes and chronic kidney disease risk: a cohort study
Yu, Q., Xu, H., Yang, Q., Wang, W., Zhou, R., & Yang, Y. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02211-2
Metadata
- Authors
- Blüher, M.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Blüher, Matthias
- ORCID
- Blüher, Matthias
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-03-04
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7098708
- OpenAlex
- W3009496837
- Cited by
- 1,090
- References
- 123
- Citations by year
- 2026: 197 · 2025: 222 · 2024: 213 · 2023: 162 · 2022: 155 · 2021: 105 · 2020: 35
- FWCI
- 86.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (209933838)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- metabolically healthy obesity, obesity, cardiometabolic risk, type 2 diabetes, cardiovascular disease, insulin sensitivity, beta-cell function, ectopic fat, visceral fat, liver fat, leg fat, cardiorespiratory fitness, weight loss, obesity treatment, risk stratification
- MeSH terms
- Obesity, Metabolically Benign, Cardiometabolic Risk Factors, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.